Jacob GLanville, PhD
Jacob Glanville is a serial entrepreneur, and computational immuno-engineer. He constructed and bought his first firm Distributed Bio from founding in March of 2012 to a 104M greenback sale to Charles River Laboratories in December of 2020. Throughout that interval, he developed the core enterprise mannequin, the analysis groups, and the applied sciences that enabled Distributed Bio to develop into worthwhile with out funding. As a part of the acquisition settlement, he based Centivax Inc and spun-out his property in COVID-19 therapeutics, broad-spectrum vaccines, antivenom antibodies, anti-wound pathogen antibodies, anti-CXCR5 autoimmunity therapeutics, and blood-brain barrier translation applied sciences into Centivax, the place he’s now CEO.
He has developed a number of seminal strategies within the fields of high-throughput antibody repertoire sequencing (PNAS 2009), repertoire decoding algorithms (Nature 2017), single-cell TCR receptor & phenotype sequencing (Nature Biotech, 2014), deconstructing genetic variation within the adaptive immune system (Nature Communications 2015, Nature Stories 2016, PNAS 2011, TI 2017), and computationally guided antibody library engineering (JMB 2011, JMB 2013, COSB 2015). He’s the inventor of the Centivax Common Vaccine know-how, the SuperHuman discovery library know-how, and the Tumbler know-how. He’s a Stanford College Scientific Advisory Committee member for the Sean Parker Heart for Allergy and Bronchial asthma Analysis, a Scientific Advisory Board member for the College of San Francisco’s Biotechnology program, a repeat Gates Basis/Stanford College Computational and Techniques Immunology Grant Recipient whereas a PhD Candidate with Mark Davis at Stanford, a Recipient of Pfizer Achievement award 2010 whereas Principal Scientist at Pfizer, and has been a course-founding teacher and visitor lecturer for a number of graduate-level utilized computational and methods immunology programs at Stanford and USF. Rising up watching his mother and father develop a profitable lodge and restaurant enterprise (La Posada de Santiago) in Guatemala in a Tzutujil village throughout a civil warfare, he was glad to search out operating a biotechnology startup to be comparable in lots of respects, with lots of the classes discovered in crew administration, product refinement, consumer recruitment and haggling to be surprisingly translatable. From 2012-2019, he nurtured the imaginative and prescient of common vaccines by the creation of a worthwhile enterprise to assist the work, the constructing of an animal facility in Guatemala to show the know-how, a collaboration with the College of San Carlos, supported a global analysis crew over 4 years to show the know-how in-vivo, and managed to collect a crew of outstanding scientists from USF, Pfizer, Genentech and different locations who agreed to hitch and take part in manifesting the imaginative and prescient.
